Hyperactivity and Reduced Energy Cost of Physical Activity in Serotonin 5-HT2C Receptor Mutant Mice

  1. Katsunori Nonogaki1,
  2. Luna Abdallah1,
  3. Evan H. Goulding1,
  4. Stephen J. Bonasera1 and
  5. Laurence H. Tecott, 1
  1. 1From the Department of Psychiatry and Center for Neurobiology and Psychiatry, University of California, San Francisco, San Francisco, California

    Abstract

    We have observed late-onset obesity in mutant mice lacking the serotonin 5-HT2C receptor. Despite chronically elevated food intake, young adult mutants exhibit neither elevated adiposity nor altered glucose or fat homeostasis. However, obesity subsequently develops after 6 months of age without increases in their level of hyperphagia. In this study, we investigated determinants of energy expenditure in 5-HT2C receptor mutant mice. Young adult mutants displayed patterns of elevated activity levels that were enhanced by fasting and tightly associated with repeated visits to a food source. Surprisingly, subsequent obesity development occurred despite persisting locomotor hyperactivity and without age-related declines in resting metabolic rate. Rather, substantial reductions in the energy cost of locomotor activity (LA) were observed in 5-HT2C receptor mutant mice. Moreover, both mutant and wild-type mice displayed age-related declines in the energy cost of LA, indicating that this process may be regulated by both aging and serotonergic signaling. These results indicate that a mutation of the 5-HT2C receptor gene (htr2c) increases LA, which contributes to the maintenance of normal body composition in young adult mutants despite their hyperphagia. Moreover, age-dependent reductions in the energy cost of physical activity could contribute to the subsequent development of late-onset obesity in 5-HT2C receptor mutant mice.

    Footnotes

    • Address correspondence and reprint requests to Laurence H. Tecott, Department of Psychiatry and Center for Neurobiology and Psychiatry, University of California, San Francisco, San Francisco, CA 94143-0984. E-mail: tecott{at}itsa.ucsf.edu.

      Received for publication 24 June 2002 and accepted in revised form 18 October 2002.

      K.N. and L.A. contributed equally to this work.

      K.N. is currently located at the Third Department of Internal Medicine, Nagoya University School of Medicine, Nagoya, Aichi, Japan.

      5-HT, 5-hydroxytryptamine; LA, locomotor activity; SNS, sympathetic nervous system.

    « Previous | Next Article »Table of Contents